| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.9M | — |
| R&D Expense | $93.6M | -3.2% |
| SG&A Expense | $50.9M | +14.4% |
| Operating Income | -$138.6M | +1.9% |
| Income Tax | $0 | — |
| Net Income | -$126.6M | +7.3% |
| EPS (Basic) | -$1.96 | +16.6% |
| EPS (Diluted) | -$1.96 | +16.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $66.4M | -28.7% |
| Short-term Investments | $197.9M | +6.5% |
| Accounts Receivable | $4.0M | +902.5% |
| Current Assets | $272.6M | -5.0% |
| Total Assets | $374.8M | -0.4% |
| Current Liabilities | $39.9M | +108.4% |
| Total Liabilities | $171.6M | +83.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$52.7M | +48.5% |
| Capital Expenditures | $7.4M | -16.0% |
| Investing Cash Flow | -$9.7M | +95.0% |
| Financing Cash Flow | $35.8M | +175.7% |
| Free Cash Flow | -$60.1M | +45.9% |
| Stockholders' Equity |
| $203.1M |
| -28.1% |